Literature DB >> 26768127

Lipoprotein LpqS deficient M. tuberculosis mutant is attenuated for virulence in vivo and shows protective efficacy better than BCG in guinea pigs.

Suba Sakthi1, Kannan Palaniyandi1, Umesh D Gupta2, Pushpa Gupta2, Sujatha Narayanan3.   

Abstract

Bacterial lipoproteins are a functionally diverse class of membrane anchored proteins. Lipoproteins constitute nearly 2.5% of the Mycobacterium tuberculosis proteome. Inactivation of genes coding for individual lipoproteins results in attenuated phenotype of the mutants. LpqS is a lipoprotein highly conserved among slow growing pathogenic mycobacteria. Our previous study has shown that the lpqS gene deletion mutant of M. tuberculosis (MtbΔlpqS) poorly replicates in THP1-(human acute monocytic leukemia cell line) derived macrophagic cell line. In addition, guinea pigs, when infected with the mutant strain exhibited significantly reduced bacterial burden and pathological damage in the infected tissues in comparison with the parental strain infected group. Subsequently, we evaluated the protective efficacy of the mutant by immunization of guinea pigs through aerosol and subcutaneous routes. We observed that immunization of guinea pigs with MtbΔlpqS offered superior protection in lungs as compared to BCG. In addition, MtbΔlpqS also prevented the haematogenous spread of the disease which was evident from the significantly reduced splenic bacillary load compared to saline vaccinated animals. The gross pathological observations and the histopathological observations well corroborated the bacterial findings. We also observed that aerogenic route of immunization imparts superior protection compared to subcutaneous route of immunization. These findings well establishes the efficacy of M. tuberculosis mutant in imparting protection against pulmonary TB.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Gene deletion mutant; Guinea pig model; Live attenuated vaccines; M. tuberculosis; MtbΔlpqS

Mesh:

Substances:

Year:  2016        PMID: 26768127     DOI: 10.1016/j.vaccine.2015.12.059

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Pharmacokinetics and Adverse Effects of 3 Sustained-release Buprenorphine Dosages in Healthy Guinea Pigs (Cavia porcellus).

Authors:  Andrea S Zanetti; Sumanth K Putta; Donald B Casebolt; Stan G Louie
Journal:  J Am Assoc Lab Anim Sci       Date:  2017-11-01       Impact factor: 1.232

Review 2.  The current status, challenges, and future developments of new tuberculosis vaccines.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Hum Vaccin Immunother       Date:  2018-05-14       Impact factor: 3.452

Review 3.  Animal Models of Tuberculosis Vaccine Research: An Important Component in the Fight against Tuberculosis.

Authors:  Wenping Gong; Yan Liang; Xueqiong Wu
Journal:  Biomed Res Int       Date:  2020-01-02       Impact factor: 3.411

4.  Hydrophobic Mycobacterial Antigens Elicit Polyfunctional T Cells in Mycobacterium bovis Immunized Cattle: Association With Protection Against Challenge?

Authors:  Lindert Benedictus; Sabine Steinbach; Thomas Holder; Douwe Bakker; Christina Vrettou; W Ivan Morrison; Martin Vordermeier; Timothy Connelley
Journal:  Front Immunol       Date:  2020-11-12       Impact factor: 7.561

5.  Comparative Genomics of Mycobacterium avium Complex Reveals Signatures of Environment-Specific Adaptation and Community Acquisition.

Authors:  Eric C Keen; JooHee Choi; Meghan A Wallace; Michelle Azar; Carlos R Mejia-Chew; Shail B Mehta; Thomas C Bailey; Lindsay J Caverly; Carey-Ann D Burnham; Gautam Dantas
Journal:  mSystems       Date:  2021-10-19       Impact factor: 6.496

6.  An attenuated quadruple gene mutant of Mycobacterium tuberculosis imparts protection against tuberculosis in guinea pigs.

Authors:  Ritika Kar Bahal; Shubhita Mathur; Priyanka Chauhan; Anil K Tyagi
Journal:  Biol Open       Date:  2018-01-05       Impact factor: 2.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.